Top

Published in:

01-08-2018 | Original Article

Host serum microRNA profiling during the early stage of foot-and-mouth disease virus infection

Authors: Suresh H. Basagoudanavar, Madhusudan Hosamani, R. P. Tamil Selvan, B. P. Sreenivasa, Aniket Sanyal, R. Venkataramanan

Published in: Archives of Virology | Issue 8/2018

Abstract

Foot-and-mouth disease virus (FMDV) causes a highly contagious infection in cloven-hoofed animals, with many outbreaks in the developing world. MicroRNAs (miRNAs) are non-coding RNAs that regulate antiviral defence by post-transcriptional regulation of gene expression. In this study, the host miRNA response following FMDV infection was investigated in cattle, a natural host for FMDV. A significant alteration in serum miRNA expression was detected at early stages of infection. Compared to prior to infection, on day 2 postinfection (PI), 119 miRNAs were upregulated, of which 39 were significantly upregulated (P < 0.05). Gene target prediction and pathway enrichment analysis suggested that upregulated miRNAs target innate immune signalling pathways, suggesting a homeostasis effect, possibly to limit inappropriate immune responses. Further, for the significantly upregulated miRNAs, nine miRNA recognition elements were identified in the genome sequence of FMDV serotype O, which was used for infection. The antiviral effect of four of these miRNAs was confirmed in a cell culture system. These data demonstrate that changes in miRNA expression occur during early pathogenesis, and the identification of possible miRNA targets genes could help in elucidating molecular events involved in virus-host interaction and thus could be useful in developing therapeutic strategies.

Available only for authorised users

Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL (2005) Comparative genomics of foot-and-mouth disease virus. J Virol 79(10):6487–6504. https://doi.org/10.1128/JVI.79.10.6487-6504.2005 CrossRefPubMedPubMedCentral

Carpenter TE, O’Brien JM, Hagerman AD, McCarl BA (2011) Epidemic and economic impacts of delayed detection of foot-and-mouth disease: a case study of a simulated outbreak in California. J Vet Diagn Invest 23(1):26–33. https://doi.org/10.1177/104063871102300104 CrossRefPubMed

Samuel AR, Knowles NJ (2001) Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol 82(Pt 3):609–621. https://doi.org/10.1099/0022-1317-82-3-609 CrossRefPubMed

Arzt J, Pacheco JM, Stenfeldt C, Rodriguez LL (2017) Pathogenesis of virulent and attenuated foot-and-mouth disease virus in cattle. Virol J 14(1):89. https://doi.org/10.1186/s12985-017-0758-9 CrossRefPubMedPubMedCentral

Arzt J, Pacheco JM, Smoliga GR, Tucker MT, Bishop E, Pauszek SJ, Hartwig EJ, de los Santos T, Rodriguez LL (2014) Foot-and-mouth disease virus virulence in cattle is co-determined by viral replication dynamics and route of infection. Virology 452–453:12–22. https://doi.org/10.1016/j.virol.2014.01.001 CrossRefPubMed

Moraes MP, de Los Santos T, Koster M, Turecek T, Wang H, Andreyev VG, Grubman MJ (2007) Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J Virol 81(13):7124–7135. https://doi.org/10.1128/JVI.02775-06 CrossRefPubMedPubMedCentral

Ahl R, Rump A (1976) Assay of bovine interferons in cultures of the porcine cell line IB-RS-2. Infect Immun 14(3):603–606PubMedPubMedCentral

Chinsangaram J, Moraes MP, Koster M, Grubman MJ (2003) Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J Virol 77(2):1621–1625CrossRefPubMedPubMedCentral

Bronevetsky Y, Ansel KM (2013) Regulation of miRNA biogenesis and turnover in the immune system. Immunol Rev 253(1):304–316. https://doi.org/10.1111/imr.12059 CrossRefPubMedPubMedCentral

10.

Melo CA, Melo SA (2014) Biogenesis and physiology of MicroRNAs. In: Fabbri M (ed) Non-coding RNAs and Cancer. Springer, New York, pp 5–24CrossRef

11.

Lui PY, Jin DY, Stevenson NJ (2015) MicroRNA: master controllers of intracellular signaling pathways. Cell Mol Life Sci 72(18):3531–3542. https://doi.org/10.1007/s00018-015-1940-0 CrossRefPubMed

12.

Skalsky RL, Cullen BR (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64:123–141. https://doi.org/10.1146/annurev.micro.112408.134243 CrossRefPubMedPubMedCentral

13.

Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O (2005) A cellular microRNA mediates antiviral defense in human cells. Science 308(5721):557–560. https://doi.org/10.1126/science.1108784 CrossRefPubMed

14.

Scheel TK, Luna JM, Liniger M, Nishiuchi E, Rozen-Gagnon K, Shlomai A, Auray G, Gerber M, Fak J, Keller I, Bruggmann R, Darnell RB, Ruggli N, Rice CM (2016) A broad RNA virus survey reveals both miRNA dependence and functional sequestration. Cell Host Microbe 19(3):409–423. https://doi.org/10.1016/j.chom.2016.02.007 CrossRefPubMedPubMedCentral

15.

Zhang KS, Liu YJ, Kong HJ, Cheng WW, Shang YJ, Tian H, Zheng HX, Guo JH, Liu XT (2014) Identification and analysis of differential miRNAs in PK-15 cells after foot-and-mouth disease virus infection. PLoS One 9(3):e90865. https://doi.org/10.1371/journal.pone.0090865 CrossRefPubMedPubMedCentral

16.

Du J, Guo X, Gao S, Luo J, Gong X, Hao C, Yang B, Lin T, Shao J, Cong G, Chang H (2014) Induction of protection against foot-and-mouth disease virus in cell culture and transgenic suckling mice by miRNA targeting integrin alphav receptor. J Biotechnol 187:154–161. https://doi.org/10.1016/j.jbiotec.2014.07.001 CrossRefPubMed

17.

Iguchi H, Kosaka N, Ochiya T (2010) Secretory microRNAs as a versatile communication tool. Commun Integr Biol 3(5):478–481. https://doi.org/10.4161/cib.3.5.12693 CrossRefPubMedPubMedCentral

18.

Correia CN, Nalpas NC, McLoughlin KE, Browne JA, Gordon SV, MacHugh DE, Shaughnessy RG (2017) Circulating microRNAs as potential biomarkers of infectious disease. Front Immunol 8:118. https://doi.org/10.3389/fimmu.2017.00118 CrossRefPubMedPubMedCentral

19.

Stenfeldt C, Arzt J, Smoliga G, LaRocco M, Gutkoska J, Lawrence P (2017) Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection. Virol J 14(1):71. https://doi.org/10.1186/s12985-017-0743-3 CrossRefPubMedPubMedCentral

20.

Chase-Topping ME, Handel I, Bankowski BM, Juleff ND, Gibson D, Cox SJ, Windsor MA, Reid E, Doel C, Howey R, Barnett PV, Woolhouse ME, Charleston B (2013) Understanding foot-and-mouth disease virus transmission biology: identification of the indicators of infectiousness. Vet Res 44:46. https://doi.org/10.1186/1297-9716-44-46 CrossRefPubMedPubMedCentral

21.

OIE (2017) Foot-and-mouth disease. In: Manual of diagnostic tests and vaccines for terrestrial animals. World organization for animal health web. http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.01.08_FMD.pdf. Accessed 31 Mar 2018

22.

Hosamani M, Basagoudanavar SH, Tamil Selvan RP, Das V, Ngangom P, Sreenivasa BP, Hegde R, Venkataramanan R (2015) A multi-species indirect ELISA for detection of non-structural protein 3ABC specific antibodies to foot-and-mouth disease virus. Arch Virol 160(4):937–944. https://doi.org/10.1007/s00705-015-2339-9 CrossRefPubMed

23.

Reid SM, Ferris NP, Hutchings GH, Zhang Z, Belsham GJ, Alexandersen S (2002) Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay. J Virol Methods 105(1):67–80CrossRefPubMed

24.

Rodriguez-Calvo T, Diaz-San Segundo F, Sanz-Ramos M, Sevilla N (2011) A replication analysis of foot-and-mouth disease virus in swine lymphoid tissue might indicate a putative carrier stage in pigs. Vet Res 42:22. https://doi.org/10.1186/1297-9716-42-22 CrossRefPubMedPubMedCentral

25.

Basagoudanavar SH, Hosamani M, Tamil Selvan RP, Sreenivasa BP, Saravanan P, Chandrasekhar Sagar BK, Venkataramanan R (2013) Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for seromonitoring vaccinated animals. Arch Virol 158(5):993–1001. https://doi.org/10.1007/s00705-012-1567-5 CrossRefPubMed

26.

Vejnar CE, Zdobnov EM (2012) MiRmap: comprehensive prediction of microRNA target repression strength. Nucleic Acids Res 40(22):11673–11683. https://doi.org/10.1093/nar/gks901 CrossRefPubMedPubMedCentral

27.

Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife. https://doi.org/10.7554/eLife.05005 CrossRefPubMedPubMedCentral

28.

Mi H, Poudel S, Muruganujan A, Casagrande JT, Thomas PD (2016) PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res 44(D1):D336–D342. https://doi.org/10.1093/nar/gkv1194 CrossRefPubMed

29.

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262 CrossRefPubMed

30.

Bae IS, Chung KY, Yi J, Kim TI, Choi HS, Cho YM, Choi I, Kim SH (2015) Identification of reference genes for relative quantification of circulating microRNAs in bovine serum. PLoS One 10(3):e0122554. https://doi.org/10.1371/journal.pone.0122554 CrossRefPubMedPubMedCentral

31.

Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. American J Hygiene 27:493–497

32.

Lawless N, Vegh P, O’Farrelly C, Lynn DJ (2014) The Role of microRNAs in Bovine Infection and Immunity. Front Immunol 5:611. https://doi.org/10.3389/fimmu.2014.00611 CrossRefPubMedPubMedCentral

33.

Arzt J, Pacheco JM, Rodriguez LL (2010) The early pathogenesis of foot-and-mouth disease in cattle after aerosol inoculation. Identification of the nasopharynx as the primary site of infection. Vet Pathol 47(6):1048–1063. https://doi.org/10.1177/0300985810372509 CrossRefPubMed

34.

Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39(16):7223–7233. https://doi.org/10.1093/nar/gkr254 CrossRefPubMedPubMedCentral

35.

Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50(4):298–301. https://doi.org/10.1016/j.ymeth.2010.01.032 CrossRefPubMedPubMedCentral

36.

Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70(23):9798–9807. https://doi.org/10.1158/0008-5472.CAN-10-1001 CrossRefPubMed

37.

van der Spek PJ, Kremer A, Murry L, Walker MG (2003) Are gene expression microarray analyses reliable? A review of studies of retinoic acid responsive genes. Genom Proteom Bioinform 1(1):9–14CrossRef

38.

Morey JS, Ryan JC, Van Dolah FM (2006) Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online 8:175–193. https://doi.org/10.1251/bpo126 CrossRefPubMedPubMedCentral

39.

Caballero IS, Honko AN, Gire SK, Winnicki SM, Mele M, Gerhardinger C, Lin AE, Rinn JL, Sabeti PC, Hensley LE, Connor JH (2016) In vivo Ebola virus infection leads to a strong innate response in circulating immune cells. BMC Genom 17:707. https://doi.org/10.1186/s12864-016-3060-0 CrossRef

40.

Liu Q, Zhou YH, Yang ZQ (2016) The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol 13(1):3–10. https://doi.org/10.1038/cmi.2015.74 CrossRefPubMed

41.

Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG (2012) Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76(1):16–32. https://doi.org/10.1128/MMBR.05015-11 CrossRefPubMedPubMedCentral

42.

Aguado LC, Schmid S, Sachs D, Shim JV, Lim JK, tenOever BR (2015) microRNA function is limited to cytokine control in the acute response to virus infection. Cell Host Microbe 18(6):714–722. https://doi.org/10.1016/j.chom.2015.11.003 CrossRefPubMedPubMedCentral

43.

Zhu JJ, Arzt J, Puckette MC, Smoliga GR, Pacheco JM, Rodriguez LL (2013) Mechanisms of foot-and-mouth disease virus tropism inferred from differential tissue gene expression. PLoS One 8(5):e64119. https://doi.org/10.1371/journal.pone.0064119 CrossRefPubMedPubMedCentral

44.

Knowlton KU, Badorff C (1999) The immune system in viral myocarditis: maintaining the balance. Circ Res 85(6):559–561CrossRefPubMed

Title: Host serum microRNA profiling during the early stage of foot-and-mouth disease virus infection
Authors: Suresh H. Basagoudanavar
Madhusudan Hosamani
R. P. Tamil Selvan
B. P. Sreenivasa
Aniket Sanyal
R. Venkataramanan
Publication date: 01-08-2018
Publisher: Springer Vienna
Published in: Archives of Virology / Issue 8/2018
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-018-3824-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Host serum microRNA profiling during the early stage of foot-and-mouth disease virus infection

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2018

Isolation and characterization of a group of new Proteus bacteriophages

Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice

A novel endornavirus isolated from cluster bean (Cyamopsis tetragonoloba)

Complete nucleotide sequences of the large RNA genome segments of Main Drain and Northway viruses (family Peribunyaviridae)

Marc H. van Regenmortel

Viral species, viral genomes and HIV vaccine design: is the rational design of biological complexity a utopia?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page